I kind of like Japan's system based on what I've read so far, but I'm still not sure of one thing:
Does regulated pricing have a chilling effect on drug companies?
It seems like it would be impossible for a Japanese drug company to be viable if the government gets to fix the price so that anyone can afford it seeing as new drugs can cost billions to develop.
The disaster that is the US healthcare system is architected to eliminate any concept of price transparency to directly confound free market processes, and is costly to line the pockets of middlemen and pharmaceutical and medical/biotech firms, because their pockets aren't being lined elsewhere in what is an essential and large global industry. The US effectively subsidizes healthcare around the world by paying out the nose, and the entire thing is perpetrated against the American people by intentionally introducing smoke and mirrors to the process.
Suddenly we'd be paying a lot less and if we are subsidizing the cost it'll for them to raise prices in those other countries.
It's almost Trumpian in its vague, implausible and detail-free appeal to the baser instincts in order deflect from clear and obvious fraud.
2k USD for a few stitchies? That's still insanely high.